Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sighild Lemarchant

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Frontiers in Physiology|September 18, 2025
Blood-spinal cord barrier alterations in a mouse model of centrifugation-induced hypergravityDavid Dubayle, Jean-Luc Morel, Sighild Lemarchant
Journal of Neuroscience Research|January 14, 2017
ADAMTS-4 in central nervous system pathologiesSighild Lemarchant, Sara Wojciechowski, Denis Vivien, et al.
The AAPS Journal|September 15, 2017
Early to Long-Term Alterations of CNS Barriers After Traumatic Brain Injury: Considerations for Drug DevelopmentBeatriz Rodriguez-Grande, Aleksandra Ichkova, Sighild Lemarchant, et al.
Neuroscience|February 12, 2021
SCO-spondin-derived Peptide Protects Neurons from Glutamate-induced ExcitotoxicityNathalie Delétage, Juliette Le Douce, Noëlle Callizot, et al.
Frontiers in Neuroscience|July 1, 2021
Subcommissural Organ-Spondin-Derived Peptide Restores Memory in a Mouse Model of Alzheimer's DiseaseJuliette Le Douce, Nathalie Delétage, Valérie Bourdès, et al.
Neuropharmacology|November 15, 2011
tPA in the injured central nervous system: different scenarios starring the same actor?Sighild Lemarchant, Fabian Docagne, Evelyne Emery, et al.
Journal of Neuroinflammation|November 2, 2013
ADAMTS proteoglycanases in the physiological and pathological central nervous systemSighild Lemarchant, Mathilde Pruvost, Joan Montaner, et al.
Fluids and Barriers of the CNS|September 28, 2024
NX210c drug candidate peptide strengthens mouse and human blood-brain barriersChris Greene, Nicolas Rebergue, Gwen Fewell, et al.
International Journal of Molecular Sciences|August 26, 2022
NX210c Peptide Promotes Glutamatergic Receptor-Mediated Synaptic Transmission and Signaling in the Mouse Central Nervous SystemSighild Lemarchant, Mélissa Sourioux, Juliette Le Douce, et al.
Neurology and Therapy|December 21, 2024
Safety, Tolerability and Pharmacokinetic-Pharmacodynamic Relationship of NX210c Peptide in Healthy Elderly Volunteers: Randomized, Placebo-Controlled, Double-Blind, Multiple Ascending Dose StudyAnnette Janus, Daniël Dumas, Juliette Le Douce, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Frontiers in Physiology|September 18, 2025
Blood-spinal cord barrier alterations in a mouse model of centrifugation-induced hypergravityDavid Dubayle, Jean-Luc Morel, Sighild Lemarchant
Journal of Neuroscience Research|January 14, 2017
ADAMTS-4 in central nervous system pathologiesSighild Lemarchant, Sara Wojciechowski, Denis Vivien, et al.
The AAPS Journal|September 15, 2017
Early to Long-Term Alterations of CNS Barriers After Traumatic Brain Injury: Considerations for Drug DevelopmentBeatriz Rodriguez-Grande, Aleksandra Ichkova, Sighild Lemarchant, et al.
Neuroscience|February 12, 2021
SCO-spondin-derived Peptide Protects Neurons from Glutamate-induced ExcitotoxicityNathalie Delétage, Juliette Le Douce, Noëlle Callizot, et al.
Frontiers in Neuroscience|July 1, 2021
Subcommissural Organ-Spondin-Derived Peptide Restores Memory in a Mouse Model of Alzheimer's DiseaseJuliette Le Douce, Nathalie Delétage, Valérie Bourdès, et al.
Neuropharmacology|November 15, 2011
tPA in the injured central nervous system: different scenarios starring the same actor?Sighild Lemarchant, Fabian Docagne, Evelyne Emery, et al.
Journal of Neuroinflammation|November 2, 2013
ADAMTS proteoglycanases in the physiological and pathological central nervous systemSighild Lemarchant, Mathilde Pruvost, Joan Montaner, et al.
Fluids and Barriers of the CNS|September 28, 2024
NX210c drug candidate peptide strengthens mouse and human blood-brain barriersChris Greene, Nicolas Rebergue, Gwen Fewell, et al.
International Journal of Molecular Sciences|August 26, 2022
NX210c Peptide Promotes Glutamatergic Receptor-Mediated Synaptic Transmission and Signaling in the Mouse Central Nervous SystemSighild Lemarchant, Mélissa Sourioux, Juliette Le Douce, et al.
Neurology and Therapy|December 21, 2024
Safety, Tolerability and Pharmacokinetic-Pharmacodynamic Relationship of NX210c Peptide in Healthy Elderly Volunteers: Randomized, Placebo-Controlled, Double-Blind, Multiple Ascending Dose StudyAnnette Janus, Daniël Dumas, Juliette Le Douce, et al.
Pageof 3